Results 251 to 260 of about 153,127 (306)

A prometabolite strategy inhibits cardiometabolic disease in an ApoE-/- murine model of atherosclerosis. [PDF]

JCI Insight
Beckman TN, Volpatti LR, Norton de Matos S, Slezak AJ, Reda JW, Weinstock A, Ziolkowski L, Turk A, Budina E, Cao S, Borjas G, Kwon JW, deLeon O, Refvik KC, Lauterbach AL, Gomes S, Chang EB, Hubbell JA.   +17 more
europepmc   +1 more source

What anabolic–androgenic steroids reveal about the limits of current harm reduction models

Addiction, EarlyView.
Abstract Background Harm reduction has largely been shaped by responses to psychoactive drug use where the most urgent harms are acute. These models focus on overdose, blood‐borne viruses, and rapid‐onset toxicity related harms. When applied wholesale to anabolic–androgenic steroids (AAS), they obscure the distinctive pharmacology, consumer typologies,
Timothy Piatkowski, Jason M. Nagata, Suzanne Nielsen   +2 more
wiley   +1 more source

Associations of sociodemographic factors and lifestyle behaviors with the risk of cardiometabolic disease: a population-based study from the European health interview survey in Hungary. [PDF]

BMC Public Health
Nguyen CM, Zurashvili S, Ghanem AS, Ambrocio RPP, Móré M, Nagy AC.   +5 more
europepmc   +1 more source

Cluster analysis reveals distinct inflammatory phenotypes in cardiometabolic disease. [PDF]

Cardiovasc Diabetol Endocrinol Rep
Bianchi J, Duarte FO, Camillo L, Godoy KF, Rodolpho JMA, Fragelli BDL, Espósito MCC, Branco LA, Speglich C, Roscani MG, Pott H, Anibal FF.   +11 more
europepmc   +1 more source

Adipokines in Obese Asthma: A Complex Relationship Influenced More by Sex, Weight, and Oral Steroid Treatment Than Disease Severity

Allergy, EarlyView.
Adipokine secretion from adipose tissue may be involved in obesity‐related asthma, but it is unknown how adipokine levels relate to asthma characteristics. Plasma adipokines were measured in well‐characterized lean, overweight or obese patients with mild‐to‐moderate or severe asthma.
Lars I. Andersson, Maciej Kupczyk, Barbro Dahlén, Kenji Izuhara, Mina Gaga, Nikos M. Siafakas, Alberto Papi, Bianca Beghe, Guy Joos, Klaus F. Rabe, Elisabeth H. Bel, Sebastian L. Johnston, Pascal Chanez, Mark Gjomarkaj, Peter H. Howarth, Ewa Niżankowska‐Mogilnicka, Roelinde Middelveld, Sven‐Erik Dahlén, Apostolos Bossios, Anna James, on behalf of the BIOAIR (Longitudinal Assessment of Clinical Course and BIOmarkers in Severe Chronic AIRway Disease) and ChAMP consortia   +20 more
wiley   +1 more source

Neighborhood walkability and cardiometabolic disease in Texas. [PDF]

Sci Rep
Yang M, Wang T.
europepmc   +1 more source

Cardiometabolic disease management: influences from epigenetics. [PDF]

Epigenomics
Atzemian N, Mohammed S, Di Venanzio L, Gorica E, Costantino S, Ruschitzka F, Paneni F.   +6 more
europepmc   +1 more source

Extreme Heat, Social Factors, and Mortality Among California Veterans With Cardiometabolic Disease.

JAMA Netw Open
Shannon EM, Chen L, Yuan A, Chary A, Gabrielian S, Eisenman DP, Washington DL.   +6 more
europepmc   +1 more source

Engagement With Conversational Agent-Enabled Interventions in Cardiometabolic Disease Self-Management: Systematic Review. [PDF]

JMIR Mhealth Uhealth
Kashyap N, Sebastian AT, Lynch C, Jansons P, Maddison R, Dingler T, Oldenburg B.   +6 more
europepmc   +1 more source

Timing of Delivery in Preeclampsia: Time to Reconsider?

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
Rebecca Horgan, Ahmed S. Z. Moustafa, Mackenzi Mchugh, Tetsuya Kawakita, Baha Sibai, George Saade   +5 more
wiley   +1 more source